Clinical Trial Update: A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating the safety of Cal-1 (LVsh5/C46) in an HIV-1-infected patient with high-risk lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Lymphoma

Drugs mentioned

• Cal-1 (LVsh5/C46) Drug Product

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: HIV-1 Infection | Phase 1, Phase 2 | Status: COMPLETED